
Company valuation, historical trends, and peer comparisons.
According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 220.34M. This represents a change of -28.84% compared to the average of 309.63M of the last 4 quarters.
The mean historical Enterprise Value of Newron Pharmaceuticals S.p.A. over the last ten years is 157.07M. The current 220.34M Enterprise Value has changed 40.29% with respect to the historical average. Over the past ten years (40 quarters), NWPHF's Enterprise Value was at its highest in in the December 2025 quarter at 537.26M. The Enterprise Value was at its lowest in in the June 2007 quarter at 0.
Average
157.07M
Median
110.00M
Minimum
45.92M
Maximum
537.26M
Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 143.92%
Maximum Annual Enterprise Value = 537.26M
Minimum Annual Increase = -51.00%
Minimum Annual Enterprise Value = 45.92M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 537.26M | 143.92% |
| 2024 | 220.26M | 60.57% |
| 2023 | 137.18M | 127.97% |
| 2022 | 60.17M | 31.05% |
| 2021 | 45.92M | -5.54% |
| 2020 | 48.61M | -51.00% |
| 2019 | 99.20M | 46.01% |
| 2018 | 67.94M | -43.76% |
| 2017 | 120.79M | -48.23% |
| 2016 | 233.34M | -18.76% |
The current Enterprise Value of Newron Pharmaceuticals S.p.A. (NWPHF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
298.23M
5-year avg
200.16M
10-year avg
157.07M
Newron Pharmaceuticals S.p.A.’s Enterprise Value is greater than Faron Pharmaceuticals Oy (62.33M), less than AnGes, Inc. (11.21B), less than Hamilton Thorne Ltd. (265.04M), less than Opsens Inc. (325.99M), greater than Recce Pharmaceuticals Ltd (113.24M), greater than Adocia S.A. (62.50M), less than Dialogue Health Technologies Inc. (284.85M), less than NIOX Group Plc (253.79M), greater than Planet 13 Holdings Inc. (74.42M), less than Guerbet S.A. (431.88M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 62.33M | $209.54M | |
| 11.21B | $143.66M | |
| 265.04M | $245.15M | |
| 325.99M | $247.43M | |
| 113.24M | $67.27M | |
| 62.50M | $170.44M | |
| 284.85M | $254.80M | |
| 253.79M | $364.27M | |
| 74.42M | $202.02M | |
| 431.88M | $281.03M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Newron Pharmaceuticals S.p.A.'s Enterprise Value?
What is the highest Enterprise Value for Newron Pharmaceuticals S.p.A. (NWPHF)?
What is the 3-year average Enterprise Value for Newron Pharmaceuticals S.p.A. (NWPHF)?
What is the 5-year average Enterprise Value for Newron Pharmaceuticals S.p.A. (NWPHF)?
How does the current Enterprise Value for Newron Pharmaceuticals S.p.A. (NWPHF) compare to its historical average?